Recent Comments

U.S. government resumes medical evacuations from Haiti; new food voucher distribution targeting women begins (1)
Lourey wrote: How comes it happens to a country that is already … [More]
Race differences in average IQ are largely genetic (75)
RightofRush wrote: Mr. Katanga, I'm sure that you are aware of the in… [More]
Groundbreaking technologies and design innovations can improve older people's quality of life (1)
Sylvia wrote: Dot was a lady who had a brain tumour in 1998 and … [More]
Legalising cannabis: School children debate (1)
Blair Anderson wrote: Unquestionably a topic of the day. And honourably … [More]
Race differences in average IQ are largely genetic (75)
persephone wrote: Brain size has nothing to do with intelligence, th… [More]
LCA-Vision to provide free corrective vision surgery to U.S. military veterans (4)
Scott wrote: Just wondering if this is for the Veterans or the … [More]

<< Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells | TENS therapy is not effective against chronic low-back pain >>

Endo Pharmaceuticals to reviews its products and development programs at Annual Healthcare Conference

31. December 2009 03:45

Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the J.P. Morgan 28th Annual Healthcare Conference on Wednesday, Jan. 13, 2010, at 10:00 a.m. PST. David Holveck, president and chief executive officer of Endo, will review the company's products and development programs.

The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section.

SOURCE Endo Pharmaceuticals

1dff750f-4a79-4b29-b47a-3d5a74578657|1|4.0

Posted in: Pharmaceutical News

Tags: Anti-Inflammatory, Cancer, Carcinoma, Endocrinology, Migraine, Neuralgia, Neurology, Oncology, Osteoarthritis, Prostate Cancer, Puberty, Urology, Voltaren

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERMEndo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma...Prolonged exposure to formaldehyde linked with increased risk of myeloid leukemiaLong durations of exposure to formaldehyde used for embalming in the funeral industry were associate...GSK reports positive Phase II results from trial evaluating GSK1838262 for post-herpetic neuralgiaGlaxoSmithKline and XenoPort, Inc. today announced top-line results from a Phase II clinical trial e...Discovery of potent metastasis inhibitorResearchers at Children's Hospital Boston have isolated a potent inhibitor of tumor metastasis made ...Findings in epilepsy gene in animals may guide treatment directions for infantsResearchers studying a difficult-to-treat form of childhood epilepsy called infantile spasms have de...FDA approves tapentadol immediate-release tablets for pain in adultsMillions of Americans with moderate to severe acute pain and their health-care providers will soon h...Epilepsy drug may raise the risk of birth defectsScientists have found that women who take an epilepsy drug while they are pregnant may increase the ...Modified chemotherapy regimen promising for lymphoma patients in the developing worldPreliminary results suggest that patients with aggressive non-Hodgkin's lymphoma in the developing w...Bone mineral content continues to increase in obese adolescents during weight lossObese teenagers who succeeded in losing weight in a year-long medically supervised weight control pr...Compound found in elderberry could give a natural boost to skinForget expensive moisturisers and cosmetic surgery, a compound found in the humble elderberry could ...Time for FDA to set the record straight on common painkillersThe U.S. Food and Drug Administration (FDA) has caused an unnecessary scare about some pain reliever...Taxotere shows significant survival benefit in the treatment of advanced gastric cancerFinal results from the largest international study in the treatment of advanced stomach cancer, also...Prostate Robotic System that will improve the diagnosis and treatment of prostate cancerThe Singapore General Hospital and Nanyang Technological University (NTU) have jointly developed a P...

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Endo Pharmaceuticals to reviews its products and development programs at Annual Healthcare Conference

Recent Articles

New Articles

Free!

Recent Comments

Twitter

Information

Endo Pharmaceuticals to reviews its products and development programs at Annual Healthcare Conference

Medical News Cloud

Recent Articles

New Articles